Sapporo Medical Journal

Abstract : People who have mental disorders in West Java, Indonesia, are still in stocks for various reasons. people They cannot control their behavior. Their behavior is at risk of injuring themself, others, and the environment. This study aimed to analyze the effect of anthocyanin and assertive supportive group therapy on the ability to overcome the violent behavior of Schizophrenia patients in the West Java Provincial Hospital. Design this research was a Quasi-experimental research design with a pre-post test control design approach. Total samples were 36 patients, every 18 patients for the treatment and control groups. The treatment group was given assertive supportive group for 4 days. In the intervention group, after the post-test, patients were given food containing anthocyanin in the form of black sticky rice bars twice a day for 10 days. The results showed a significant difference after therapy in the assertive supportive group in the treatment group and the control group (p-value 0.000). At the same time, the anthocyanin nutrient administration did not affect (p-value 0.292). There was an effect of assertive supportive group therapy on the ability to overcome the violent behavior of Schizophrenia patients in a psychiatric hospital, West Java, Indonesia. Also, anthocyanin can bit increase the average value of the ability to cope with violent behavior. Recommendations for effective assertive supportive therapy are carried out in small groups.

Abstract : In recent years, there has been an increasing interest in the use of medical cannabis and its importance in medical treatment. Particularly, this issue of using medical cannabis has received considerable critical attention in epilepsy disorder and chronic non-cancer pain. The purpose of this paper is to review recent research to determine the effect of medical cannabis as a form of medication. It suggests that there is a positive relationship between the use of medical cannabis and the reduction in the number of seizure frequency for those who suffer from epilepsy diseases. The paper also discusses the other argument evidencing that medical cannabis has a negative effect on those with chronic non-cancer pain. Finally, it concludes that medical cannabis is useful for the treatment of epilepsy diseases. At the same time, there should also be continued efforts to make the decision about using medical cannabis more accessible for medical purposes. A major recommendation in this paper is to continue conducting further research and to have support from the government in order to consolidate this finding.

Abstract : Hypertension prevalence increased globally, especially in middle-income and lower-income countries. Smoking was one of the risk factors for triggering the non-communicable disease. Smoking behavior prevalence in Indonesia increased from 12,3% in 2013 to 24,35% in 2018. This study conducted to determine the relationship between smoking behavior and the incidence of hypertension in the medical ward at RSAU M. Salamun Bandung. The research method used was a case-control analytic survey method, which was retrospective in nature. Sampling was purposive sampling, with a total of 28 respondents. Data analysis used the chi-square test showed that there was significance between smoking behavior (p = 0.005, OR = 6,923) and the incidence of hypertension. The hospital needed to increase health education about the negative effect of smoking by campaigning and distributing leaflets or other mass health promotion media.

Abstract : The current study aimed to report the pregnant women knowledge and perception about the feto-maternal care during the pandemic's lockdown. A cross sectional anonymous questionnaire-based study took place in Saudi Arabia. Questions were electronically distributed to participants. The questionnaire includes varieties of questions to gauge their knowledge and perceptions of many pregnancy-related topics in general. It also reported their information and attitude to COVID-19 infection regarding its feto-maternal and neonatal effect and the preventive measures. Three thousand one hundred and seventy-six pregnant females participated in the study. Poor knowledge was reported in (87.9%) of respondents. Meanwhile, 384 (12.1%) had good knowledge. More than half of the women expressed a poor maternal care during the pandemic, although 1415 (44.6%) had a good one. In Conclusion, Saudi Pregnant women living in areas with a higher COVID-19 prevalence, notably, Western, Central and Eastern provinces, expressed more information about the disease. Pregnant females who previously experienced maternal complications and/ or obstructed labor were more knowledgeable about the importance of maternal care. They were eager to undergo feto maternal care, even during the pandemic lockdown. Accurate information about the relationship between COVID-19 vertical transmission and maternal complications must be widely provided to Saudi pregnant ladies.

Abstract : Preeclampsia is the leading cause of morbidity and mortality worldwide. Etiology, and pathophysiology are poorly understood with a recent theory as two stages disorder. The main hypothesis result from a defect in remodelling of spiralis artery, while late-onset preeclampsia is generally considered as maternal factor preeclampsia. Delivery remain the main treatment option, as ACOG already recommended low dose aspirin for high risk pregnancy to reduce mortality rate. Lipid abnormalities has effect on endothelial function which is the main pathogenesis and risk factor of preeclampsia. In pregnancy, lipid metabolism changes occured for fetal growth and development. Pregnant women with preeclampsia has significantly higher lipid profile. Statin is considered safe and has advantages in treating dyslipidemia. Randomized clinical trial were done to assess effect of pravastatin in 71 high risk preeclampsia pregnant women. Clinical trial were done in two groups. Control group (Group A) take 80mg aspirin only as recommended by ACOG until 36 week of pregnancy. Intervention group (Group B) take aspirin and additional 20mg pravastatin twice daily since 18 weeks until 36 week of pregnancy. Maternal lipid profile before and after treatment on both groups were assesed. Maternal outcome and baby outcome were assessed on both groups. There is no significant difference viewed from between groups on initial test of lipid profile. Even after therapy, total cholesterol and triglyceride keep on incr